DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Carbocyclic ScaffoldsCarbocyclic Scaffolds
  5. /Benzene CompoundsBenzene Compounds
  6. /TaxoprexinTaxoprexin
Chemical structure of CAS 199796-52-6

Taxoprexin

CAS No.199796-52-6
MDL No.N/A
MFC69H81NO15
MW1164.40
InChI KeyLRCZQSDQZJBHAF-PUBGEWHCSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.199796-52-6
Product NameTaxoprexin

Biological Targets

TUBB4B·TUBB1·TUBA3C·TUBA4A·TUBB3·

Associated Conditions

non-small cell lung carcinoma·hepatocellular carcinoma·metastatic melanoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.

Melanoma research • Vol. 19, Issue 4 • 2009
PMID: 19521262DOI: 10.1097/CMR.0b013e32832a1e2f

Tumor targeting by conjugation of DHA to paclitaxel.

Journal of controlled release : official journal of the Controlled Release Society • Vol. 74, Issue 1-3 • 2001
PMID: 11489499DOI: 10.1016/s0168-3659(01)00321-2

Documentation

Similar Products

  • Paclitaxel

    CAS No.33069-62-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact